/Companies

Endomedix

Montclair, US · 5 known investors

Find your way into Endomedix

Sign up to see every warm intro you have to Endomedix

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Endomedix team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Endomedix develops polysaccharide-based biomaterials and medical technology, with a pipeline moving from polysaccharide chemistry toward preclinical testing and clinical trials. The company works with a small internal R&D team supported by external scientific consultants.

Founders & leadership

PMPiyush M.
Piyush M.FounderPiyush M. is founder of Endomedix and lead inventor of a polysaccharide-based platform technology for biosurgical devices. He has expertise in biomaterials science, materials characterization, and machine learning applied to biopolymer processing, with prior experience in military and government programs.
WC
Weiliam ChenNamed on SEC filing
JR
James R. PastenaNamed on SEC filing
JM
John M. AbrahamsNamed on SEC filing
RR
Richard RussoPresident & CEO
RO
Richard OlsonNamed on SEC filing
PM
Piyush ModakVice President – Research & Development, Co-founder
KL
Kai LoActing CFO

Investors · 5

Reported raises · per SEC filings

Form D private placements

$1.2M disclosed across 1 round · 2019

▶$1.2MraisedMay 2019 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Weiliam ChenDirector
  • James R. PastenaDirector
  • John M. AbrahamsDirector
  • Richard RussoExecutive Officer, Director
  • Richard OlsonDirector
Offering amount
$2.5M
Amount sold
$1.2M
First sale
May 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Endomedix do?
Endomedix develops polysaccharide-based biomaterials and medical technology, with a pipeline moving from polysaccharide chemistry toward preclinical testing and clinical trials. The company works with a small internal R&D team supported by external scientific consultants.
Who founded Endomedix?
Endomedix was founded by Piyush M..
Who are Endomedix's investors?
Endomedix's investors include Central Texas Angel Network, Houston Angel Network, Keiretsu Forum, Symbiotic Ventures, Golden Seeds.
How much funding has Endomedix raised?
Endomedix has disclosed $1.2M raised across 1 round.
Where is Endomedix headquartered?
Endomedix is headquartered in Montclair, US.